vs
FEMASYS INC（FEMY）与Arcadia Biosciences, Inc.（RKDA）财务数据对比。点击上方公司名可切换其他公司
Arcadia Biosciences, Inc.的季度营收约是FEMASYS INC的1.1倍（$901.0K vs $813.4K），Arcadia Biosciences, Inc.净利率更高（-148.3% vs -485.7%，领先337.4%），FEMASYS INC同比增速更快（39.9% vs -25.8%），过去两年FEMASYS INC的营收复合增速更高（73.2% vs -4.5%）
Femasys Inc.是一家专注于女性健康领域的医疗科技企业，开发和商业化微创诊断及治疗设备，核心产品线覆盖生育护理、妇科、产科等领域的未满足临床需求，主要服务北美及欧洲市场的医疗机构与患者。
阿卡迪亚生物科学是一家美国上市农业生物技术企业，总部位于加利福尼亚州戴维斯，专注于开发可提升作物品质与产量的作物性状改良技术，该公司部分股权归道德指南针公司所有。
FEMY vs RKDA — 直观对比
营收规模更大
RKDA
是对方的1.1倍
$813.4K
营收增速更快
FEMY
高出65.7%
-25.8%
净利率更高
RKDA
高出337.4%
-485.7%
两年增速更快
FEMY
近两年复合增速
-4.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $813.4K | $901.0K |
| 净利润 | $-4.0M | $-1.3M |
| 毛利率 | 62.7% | 21.4% |
| 营业利润率 | -568.3% | -152.8% |
| 净利率 | -485.7% | -148.3% |
| 营收同比 | 39.9% | -25.8% |
| 净利润同比 | 22.9% | 67.1% |
| 每股收益（稀释后） | $0.02 | $-0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FEMYRKDA
| Q4 25 | $813.4K | $901.0K | ||
| Q3 25 | $729.4K | $1.3M | ||
| Q2 25 | $409.3K | $1.5M | ||
| Q1 25 | $341.3K | $1.2M | ||
| Q4 24 | $581.6K | $1.2M | ||
| Q3 24 | $554.9K | $1.5M | ||
| Q2 24 | $221.5K | $1.3M | ||
| Q1 24 | $271.1K | $987.0K |
净利润FEMYRKDA
| Q4 25 | $-4.0M | $-1.3M | ||
| Q3 25 | $-4.2M | $856.0K | ||
| Q2 25 | $-4.6M | $-4.5M | ||
| Q1 25 | $-5.9M | $2.6M | ||
| Q4 24 | $-5.1M | $-4.1M | ||
| Q3 24 | $-5.4M | $-1.6M | ||
| Q2 24 | $-4.7M | $1.1M | ||
| Q1 24 | $-3.6M | $-2.4M |
毛利率FEMYRKDA
| Q4 25 | 62.7% | 21.4% | ||
| Q3 25 | 59.7% | 32.1% | ||
| Q2 25 | 61.4% | 43.4% | ||
| Q1 25 | 65.6% | 43.2% | ||
| Q4 24 | 66.9% | 31.9% | ||
| Q3 24 | 65.6% | 32.9% | ||
| Q2 24 | 67.0% | 51.5% | ||
| Q1 24 | 67.3% | 52.3% |
营业利润率FEMYRKDA
| Q4 25 | -568.3% | -152.8% | ||
| Q3 25 | -500.9% | -88.5% | ||
| Q2 25 | -941.1% | -34.4% | ||
| Q1 25 | -1600.1% | 44.2% | ||
| Q4 24 | -812.0% | -187.7% | ||
| Q3 24 | -922.4% | -114.5% | ||
| Q2 24 | -2023.7% | — | ||
| Q1 24 | -1277.1% | -160.9% |
净利率FEMYRKDA
| Q4 25 | -485.7% | -148.3% | ||
| Q3 25 | -575.1% | 65.7% | ||
| Q2 25 | -1120.5% | -306.4% | ||
| Q1 25 | -1727.9% | 216.6% | ||
| Q4 24 | -881.0% | -334.5% | ||
| Q3 24 | -974.7% | -104.9% | ||
| Q2 24 | -2115.1% | 81.2% | ||
| Q1 24 | -1327.5% | -245.5% |
每股收益（稀释后）FEMYRKDA
| Q4 25 | $0.02 | $-0.97 | ||
| Q3 25 | $-0.10 | $0.62 | ||
| Q2 25 | $-0.16 | $-3.26 | ||
| Q1 25 | $-0.23 | $1.90 | ||
| Q4 24 | $-0.23 | $-2.99 | ||
| Q3 24 | $-0.24 | $-1.18 | ||
| Q2 24 | $-0.21 | $0.78 | ||
| Q1 24 | $-0.17 | $-1.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.3M | $4.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.9M | $4.1M |
| 总资产 | $20.7M | $6.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FEMYRKDA
| Q4 25 | $9.3M | $4.6M | ||
| Q3 25 | $4.6M | $5.9M | ||
| Q2 25 | $3.2M | $4.4M | ||
| Q1 25 | $3.8M | $3.2M | ||
| Q4 24 | $3.5M | $4.2M | ||
| Q3 24 | $7.6M | $6.6M | ||
| Q2 24 | $13.5M | $8.1M | ||
| Q1 24 | $17.8M | $8.5M |
股东权益FEMYRKDA
| Q4 25 | $5.9M | $4.1M | ||
| Q3 25 | $4.6M | $5.4M | ||
| Q2 25 | $1.5M | $4.5M | ||
| Q1 25 | $2.0M | $8.9M | ||
| Q4 24 | $2.3M | $6.2M | ||
| Q3 24 | $6.0M | $10.3M | ||
| Q2 24 | $11.3M | $11.7M | ||
| Q1 24 | $15.6M | $10.6M |
总资产FEMYRKDA
| Q4 25 | $20.7M | $6.5M | ||
| Q3 25 | $16.3M | $8.6M | ||
| Q2 25 | $13.8M | $7.8M | ||
| Q1 25 | $13.3M | $13.0M | ||
| Q4 24 | $12.4M | $13.5M | ||
| Q3 24 | $15.6M | $15.2M | ||
| Q2 24 | $20.3M | $17.4M | ||
| Q1 24 | $24.4M | $16.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $-861.0K |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | — |
| 自由现金流率自由现金流/营收 | -531.7% | — |
| 资本支出强度资本支出/营收 | 17.2% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-19.2M | — |
8季度趋势，按日历期对齐
经营现金流FEMYRKDA
| Q4 25 | $-4.2M | $-861.0K | ||
| Q3 25 | $-5.4M | $-257.0K | ||
| Q2 25 | $-4.4M | $-2.0M | ||
| Q1 25 | $-4.8M | $-1.6M | ||
| Q4 24 | $-5.1M | $-2.2M | ||
| Q3 24 | $-5.5M | $-1.8M | ||
| Q2 24 | $-4.3M | $-2.5M | ||
| Q1 24 | $-4.6M | $-3.2M |
自由现金流FEMYRKDA
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-4.4M | — | ||
| Q1 25 | $-4.9M | — | ||
| Q4 24 | $-5.2M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $-4.5M | $-2.5M | ||
| Q1 24 | $-4.6M | $-3.2M |
自由现金流率FEMYRKDA
| Q4 25 | -531.7% | — | ||
| Q3 25 | -765.3% | — | ||
| Q2 25 | -1086.6% | — | ||
| Q1 25 | -1424.7% | — | ||
| Q4 24 | -890.9% | — | ||
| Q3 24 | -1060.1% | — | ||
| Q2 24 | -2035.8% | -188.3% | ||
| Q1 24 | -1708.6% | -326.5% |
资本支出强度FEMYRKDA
| Q4 25 | 17.2% | 0.0% | ||
| Q3 25 | 26.6% | 0.0% | ||
| Q2 25 | 23.0% | 0.0% | ||
| Q1 25 | 28.3% | 0.0% | ||
| Q4 24 | 18.4% | 0.0% | ||
| Q3 24 | 73.5% | 0.0% | ||
| Q2 24 | 82.4% | 0.2% | ||
| Q1 24 | 23.8% | 1.3% |
现金转化率FEMYRKDA
| Q4 25 | — | — | ||
| Q3 25 | — | -0.30× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2.31× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
